Back to Search
Start Over
[Treatment of pulmonary arterial hypertension].
- Source :
-
Medicina clinica [Med Clin (Barc)] 2015 Jun 22; Vol. 144 (12), pp. 566-70. Date of Electronic Publication: 2014 Jul 26. - Publication Year :
- 2015
-
Abstract
- Treatment of pulmonary arterial hypertension has achieved significant progress over the past 20 years. Currently, 3 groups of drugs have proven useful for the treatment of this disease: endothelin receptor antagonist, phosphodiesterase inhibitors and prostacyclin and its analogues. It is recommended to initiate treatment with one of these drugs, the choice depending on the initial severity of patient disease and the preferences of the treating physician. When the patient does not have a satisfactory response, new drugs acting at a different pathway are most commonly added. At this time, considering referral for lung transplantation could be an alternative. Most experts recommend grouping maximum experience in what is known as expert centers. Treatment has led to better survival in these patients, but there is still a long way to cure this life-threatening disease.<br /> (Copyright © 2014 Elsevier España, S.L.U. All rights reserved.)
- Subjects :
- Clinical Trials as Topic
Disease Management
Drug Therapy, Combination
Exercise Tolerance
Guanylate Cyclase drug effects
Heart Atria surgery
Heart Septum surgery
Humans
Hypertension, Pulmonary drug therapy
Hypertension, Pulmonary surgery
Life Style
Palliative Care
Prostaglandins I agonists
Endothelin Receptor Antagonists therapeutic use
Hypertension, Pulmonary therapy
Lung Transplantation
Phosphodiesterase Inhibitors therapeutic use
Prostaglandins I therapeutic use
Subjects
Details
- Language :
- Spanish; Castilian
- ISSN :
- 1578-8989
- Volume :
- 144
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Medicina clinica
- Publication Type :
- Academic Journal
- Accession number :
- 25070518
- Full Text :
- https://doi.org/10.1016/j.medcli.2014.03.033